U.S. Department of Health and Human Services U.S. Department of Health and Human Services www.hhs.gov
National Institutes of Health - Research Portfolio Online Reporting Tool (RePORT) Website Reports Data and Analyses Of NIH Research and Development Activities
Site Map
 
Home Home Frequently Requested Reports Frequently Requested Reports Reports Reports Category Spending Reports NIH CRISP (Computer Retrieval of Information on Scientific Projects) – Search Funded Scientific Projects CRISP Glossary Glossary FAQs FAQS Links LINKS Request Report
NIH National Institutes of Health Research Portfolio Online Reporting Tool (RePORT) Website Reports Data and Analyses Of NIH Research and Development Activities

NIH Begins New Process to Report Detailed Funding Information - NIH made public the results of a new process for providing detailed funding information for 215 major areas of research.more...
RePORT Tutorial
NIH Biennial Report
Category Spending
Research, Condition, and Disease Categorization (RCDC)
Quick Links
NIH Extramural Data Book
PowerPoint - 12.5 MB PDF ~ 5MBWeb Version
spacer img
PubMed Central
spacer img
PubMed
spacer img
Current Operating Year NIH Budget
spacer img
FY 2009 President's Budget Request
spacer img
NIH Extramural Awards By State and Foreign Site
spacer img
NIH Extramural Awards by State and Congressional District
spacer img
spacer img
Data on New Investigators
spacer img
Estimates of Funding for Various Diseases, Conditions, Research Areas
spacer img
NIH Roadmap for Medical Research
spacer img
Award Data for Individual Organizations
  Home > Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) > Project Listing by Category  

Project Listing by Category

 Research, Condition, and Disease Categorization Process Website
Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Hepatitis - C NIDA 1K23DA020383-01A1 Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users TAYLOR, LYNN MIRIAM HOSPITAL RI $179,212
Hepatitis - C NIDA 1R01DA021550-01A2 HCV Transmission among Young IDUs in NYC EDLIN, BRIAN SUNY DOWNSTATE MEDICAL CENTER NY $834,452
Hepatitis - C NIAID 5R01AI047365-09 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $362,764
Hepatitis - C NIMH 5R01MH067990-05 Fronto-Striatal Dysfunction in IFNa-Induced Depression MILLER, ANDREW EMORY UNIVERSITY GA $261,130
Hepatitis - C NIMH 5K05MH069124-05 Pathology and Treatment of Cytokine-Induced Depression MILLER, ANDREW EMORY UNIVERSITY GA $116,932
Hepatitis - C NIAID 5R01AI057591-04 Alteration of innate immunity by HCV core HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $282,356
Hepatitis - C NIAID 5R37AI047367-09 HCV-specific T cell response WALKER, CHRISTOPHER RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $541,702
Hepatitis - C NIDDK 5F32DK067781-03 Cis- and Trans-acting Factors in HCV Gene Expression BRADRICK, SHELTON DUKE UNIVERSITY NC $52,048
Hepatitis - C NIMH 5R01MH079752-02 Role of evolving white matter damage in neurocognitive effects of HIV and HCV JERNIGAN, TERRY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $347,625
Hepatitis - C NIAID 5R01AI072613-02 Identification and characterization of cellular factors involved in HCV entry RICE, CHARLES ROCKEFELLER UNIVERSITY NY $414,473
Hepatitis - C NIAID 5R01AI065985-03 Defining NS4B Function in Hepatitis C Virus Replication BLIGHT, KERIL WASHINGTON UNIVERSITY MO $289,575
Hepatitis - C NIDDK 5R01DK064223-05 HCV NS5A: Molecular Virology and Antiviral Target GLENN, JEFFREY STANFORD UNIVERSITY CA $261,667
Hepatitis - C NIMH 5R01MH070553-04 Cytokine-CRH Interactions in IFN-alfa-Induced Depression RAISON, CHARLES EMORY UNIVERSITY GA $326,412
Hepatitis - C NIAID 5R37AI028731-19 Noncarbohydrate Approaches to AntiAIDS Nuleosides LIOTTA, DENNIS EMORY UNIVERSITY GA $324,651
Hepatitis - C NIAID 5R01AI061158-04 Mechanisms of Innate and Adaptive Immunity In HCV NELSON, DAVID UNIVERSITY OF FLORIDA FL $304,514
Hepatitis - C NIAID 5R01AI069000-03 Roles for microRNA-122 in hepatitis C virus RNA amplification SARNOW, PETER STANFORD UNIVERSITY CA $295,433
Hepatitis - C NIAID 5R01AI069142-02 Immune Mechanisms of HCV Persistence and Pathogenesis SUN, JIAREN UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $333,295
Hepatitis - C NIDA 5R01DA011598-10 Nutritional Status In HIV Hispanic Drug Abusers FORRESTER, JANET TUFTS UNIVERSITY BOSTON MA $660,216
Hepatitis - C NIMH 5K23MH071177-04 Adherence to HCV Treatment in HCV and HCV/HIV Patients WEISS, JEFFREY MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $148,791
Hepatitis - C NIAID 1R21AI076706-01 Impact of NK Cell Immune Pressures on HCV Evolution and Viral Fitness ALTFELD, MARCUS MASSACHUSETTS GENERAL HOSPITAL MA $263,250
Hepatitis - C NIAID 1R21AI076834-01 Cell Culture System for Hepatitis C Virus Genotype 1a DI BISCEGLIE, ADRIAN SAINT LOUIS UNIVERSITY MO $183,750
Hepatitis - C NIDDK 5K24DK070528-04 Mentorship in Liver Disease SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $117,084
Hepatitis - C NIAID 5R01AI069285-02 Role of TLR3 Signaling in Control of HCV LI, KUI UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $126,887
Hepatitis - C NIDDK 5R01DK066939-05 Modulation of HCV Gene Expression BRANCH, ANDREA MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $370,132
Hepatitis - C NIDDK 5R01DK070877-03 Immunoglobulin Allotypes in Hepatitis C Virus Infection PANDEY, JANARDAN MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $186,896
Hepatitis - C NIDDK 5R01DK066802-05 PATHOPHYSIOLOGY OF CRYOGLOBULINEMIC GLOMERULONEPHRITIS ALPERS, CHARLES UNIVERSITY OF WASHINGTON WA $352,173
Hepatitis - C NIAID 5R01AI069952-03 Statistical methods for modeling hepatitis C fibrosis progression BACCHETTI, PETER UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $178,477
Hepatitis - C NHLBI 5R01HL073921-05 Pathophysiology of IFN-alpha-induced Sleep Disturbances MILLER, ANDREW EMORY UNIVERSITY GA $290,143
Hepatitis - C NCI 1R01CA126807-01A1 HCV genetic variation and hepatocellular carcinoma TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $274,523
Hepatitis - C NIDA 5R01DA010164-12 The Logics for HIV Risk Among Homeless Heroin Injectors BOURGOIS, PHILIPPE UNIVERSITY OF PENNSYLVANIA PA $360,811
Hepatitis - C NIDDK 5R01DK068361-03 Role of immature DC in host defense against HCV ANTHONY, DONALD CASE WESTERN RESERVE UNIVERSITY OH $241,111
Hepatitis - C NIAID 1R01AI073335-01A2 RNA-dependent RNA Synthesis by the Hepatitis C Virus KAO, CHENG TEXAS A&M UNIVERSITY SYSTEM TX $287,713
Hepatitis - C NCCAM 1R21AT002895-01A2 Mechanisms of Action of Silymarin for Hepatitis C POLYAK, STEPHEN UNIVERSITY OF WASHINGTON WA $247,685
Hepatitis - C NIDDK 5F32DK079860-02 Characterization of the Assembly and Egress Pathway of Hepatitis C Virus SHOHDY, NADIM ROCKEFELLER UNIVERSITY NY $49,646
Hepatitis - C FIC 5R01TW006972-04 Risk Factors for HIV-1 infection Among Young Thai Men RANGSIN, RAM PHRAMONGKUTKLAO COLLEGE OF MEDICINE THAIL $51,202
Hepatitis - C NIDA 1K23DA022454-01A1 Directly Observed Hepatitis C Treatment in Methadone Clinics LITWIN, ALAIN YESHIVA UNIVERSITY NY $178,897
Hepatitis - C NCI 1K25CA127524-01A1 Biomarker Discovery for Hepatitis C Progression using Machine Learning Techniques SPRATT, HEIDI UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $126,357
Hepatitis - C NIDDK 5R21DK077575-02 Liver Disease Associated with HCV/HIV Coinfection Due to TRAIL VLAHAKIS, STACEY MAYO CLINIC COLL OF MEDICINE, ROCHESTER MN $181,300
Hepatitis - C NIDDK 1R01DK077704-01A2 Viral Hepatitis C and Lipid Homeostasis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $328,313
Hepatitis - C NIDDK 5K24DK002727-09 Cirrhosis and its complications GARCIA-TSAO, GUADALUPE YALE UNIVERSITY CT $156,104
Hepatitis - C NCI 5R21CA122523-02 Role of metallothioneins in hepatocellular carcinoma JACOB, SAMSON OHIO STATE UNIVERSITY OH $150,000
Hepatitis - C NIAID 5R01AI047347-10 Regulation of human T-cell immunity to HCV antigens ECKELS, DAVID UNIVERSITY OF UTAH UT $455,271
Hepatitis - C NIDDK 5R01DK069859-03 Genes Related to HCC Progression in LD and DD Transplant FISHER, ROBERT VIRGINIA COMMONWEALTH UNIVERSITY VA $482,550
Hepatitis - C NIAID 5R01AI065256-03 Antiretroviral Therapy and the Hepatitis C Virus SHERMAN, KENNETH UNIVERSITY OF CINCINNATI OH $686,648
Hepatitis - C NIAID 5R01AI066209-03 Viral Host Interactions in Hepatitis C GRETCH, DAVID UNIVERSITY OF WASHINGTON WA $408,680
Hepatitis - C NHLBI 5R01HL079381-05 Neutralizing Antibodies to Hepatitis C FOUNG, STEVEN STANFORD UNIVERSITY CA $589,711
Hepatitis - C NIAID 5R01AI050798-05 Functional analysis of hepatitis C virus glycoproteins MCKEATING, JANE UNIVERSITY OF BIRMINGHAM UK $200,490
Hepatitis - C NIDA 5K01DA017179-05 HCV Treatment Cost-Effectiveness in 3 IDU Populations SCHACKMAN, BRUCE WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $169,492
Hepatitis - C NIAID 5R01AI072012-02 New Antiviral Therapies for Hepatitis C Infection HERMANN, THOMAS UNIVERSITY OF CALIFORNIA SAN DIEGO CA $367,061
Hepatitis - C NCI 2R42CA121506-02 HCC diagnostics defined by fucosylated serum biomarkers MEHTA, ANAND IMMUNOTOPE, INC. PA $564,986
Hepatitis - C NIDDK 1R43DK080549-01 TGFb1 Receptor Inhibitors for Liver Fibrosis CAI, WEIZHONG ANGION BIOMEDICA CORPORATION NY $255,501
Hepatitis - C NIAID 5R21AI066957-02 Immunity of neoantigen response in HCV, HIV, and HCV-HIV ANTHONY, DONALD CASE WESTERN RESERVE UNIVERSITY OH $189,456
Hepatitis - C NCI 1R41CA132397-01 Small Molecule Inhibitors of HBV/HCV Induced Liver Diseases DHEER, SURENDRA SONITU PHARMACEUTICALS, LLC PA $168,000
Hepatitis - C NIAID 1R43AI074214-01A1 An RNAi Trojan Horse for treatment of hepatitis C. JOHNSTON, BRIAN SOMAGENICS, INC. CA $295,743
Hepatitis - C NIAID 5R43AI072780-02 Broadly Neutralizing MAbs against Hepatitis C Virus OLSON, WILLIAM PROGENICS PHARMACEUTICALS, INC. NY $287,309
Hepatitis - C NIMH 5R01MH073433-04 Neurobehavioral Effects of HIV & Host Genetics in China HEATON, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $645,840
Hepatitis - C NIDDK 5K23DK077568-02 Kidney Disease in HIV-Hepatitis C Virus Co-Infection WYATT, CHRISTINA MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $129,225
Hepatitis - C NIAID 5R01AI068769-03 QUALITATIVE NATURE OF ANTIBODIES TO HCV GLYCOPROTEIN SUBUNIT VACCINE IN HUMANS RAY, RANJIT SAINT LOUIS UNIVERSITY MO $315,056
Hepatitis - C NCI 5R01CA085888-09 Malignant Complications of Chronic HCV LOFFREDO, CHRISTOPHER GEORGETOWN UNIVERSITY DC $297,351
Hepatitis - C NIDDK 5R01DK066754-05 Impaired T cell function by HCV core HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $282,304
Hepatitis - C NIDA 5R01DA022030-03 Electronic Information System to Enhance Practice at an Opioid Treatment Program BROWN, LAWRENCE ADDICTION RESEARCH AND TREATMENT CORP NY $179,626
Hepatitis - C NIDDK 5K24DK078154-02 Epidemiology and Outcomes of Digestive and Liver Diseases: A Mentoring Program EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $149,057
Hepatitis - C NIAID 5R01AI049574-08 GBV-B: A Small Primate Model for Hepatitis C Infection LANFORD, ROBERT SOUTHWEST FOUNDATION FOR BIOMEDICAL RES TX $311,605
Hepatitis - C NIMH 1R21MH078740-01A2 Enhancing HCV Treatment Decisions in HIV Co-Infected Patients and Their Providers WAGNER, GLENN RAND CORPORATION CA $238,108
Hepatitis - C NIDA 1R21DA023893-01A1 Mediation Effect of Network Function on Transition to Injection Drug Use LIU, HONGJIE VIRGINIA COMMONWEALTH UNIVERSITY VA $215,840
Hepatitis - C NIDA 5R01DA022177-02 Opioids, HIV/HCV and Host Cell Innate Immunity HO, WENZHE CHILDREN'S HOSPITAL OF PHILADELPHIA PA $402,864
Hepatitis - C NIDA 1K01DA024654-01 Antiviral Role of APOBEC3 in HIV/HCV Coinfected Patients PILLAI, SATISH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $180,360
Hepatitis - C NIAID 2R01AI052065-05A2 HCV and HIV Progression in Women on HAART KOVACS, ANDREA UNIVERSITY OF SOUTHERN CALIFORNIA CA $533,057
Hepatitis - C NIDDK 5R21DK074891-02 Novel model of HCV infection of humanized liver in immunocompetent rats WU, GEORGE UNIVERSITY OF CONNECTICUT SCH OF MED/DNT CT $145,040
Hepatitis - C NCI 5K01CA107092-05 Hepatocellular carcinoma: targeting HCV replication LINDENBACH, BRETT YALE UNIVERSITY CT $162,378
Hepatitis - C NIDDK 5R01DK070844-03 Transplantation of Reduced-Size Fatty Livers ZHONG, ZHI MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $256,328
Hepatitis - C NCI 5R21CA128391-02 Randomized trial of doxorubicin beads for arterial embolization of hepatocellular BROWN, KAREN SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $187,000
Hepatitis - C NIDA 5R01DA020841-03 Hepatitis Care Coordination in Methadone Treatment PERLMAN, DAVID BETH ISRAEL MEDICAL CTR (NEW YORK) NY $354,372
Hepatitis - C NIAID 5K23AI065319-04 Thrombocytopenia & HIV/HCV: Risk Factors & Treatment MARKS, KRISTEN WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $131,490
Hepatitis - C NIAID 5K08AI069989-02 An in vitro system to study antiviral strategies against Hepatitis C virus WYLES, DAVID UNIVERSITY OF CALIFORNIA SAN DIEGO CA $105,570
Hepatitis - C NIDA 5R01DA020781-03 Hepatitis Care Coordination in Methadone Treatment MASSON, CARMEN UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $331,144
Hepatitis - C NIAID 5R01AI047519-10 Cellular immunity - outcome hepatitis C virus infection CHANG, KYONG-MI UNIVERSITY OF PENNSYLVANIA PA $304,162
Hepatitis - C NCI 5R21CA125321-02 Variation in NTP use by the HCV polymerase and response to therapy TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $147,000
Hepatitis - C NIDDK 1R01DK080711-01 Hepatitis C Virus Quasispecies in the Resistance to Antiviral Therapy FAN, XIAOFENG SAINT LOUIS UNIVERSITY MO $294,000
Hepatitis - C NIDDK 5R21DK078100-02 Ribavirin Pharmacokinetics, Race and HCV Treatment HOWELL, CHARLES UNIVERSITY OF MARYLAND BALTIMORE MD $181,912
Hepatitis - C NIAID 5K08AI072191-02 Mechanisms of T cell dysfunction in Hepatitis C virus persistence RADZIEWICZ, HENRY EMORY UNIVERSITY GA $128,250
Hepatitis - C NIDDK 5R01DK078857-02 Interferon modulation of cellular microRNAs in the Hepatitis C antiviral defense DAVID, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $279,351
Hepatitis - C NIDDK 5R01DK071560-04 Innate Immune Responses During Therapy for Chronic HCV ROSEN, HUGO UNIVERSITY OF COLORADO DENVER CO $270,459
Hepatitis - C NIAID 5R01AI069939-03 HIV-Hepatitis C Virus Interactions and Pathogenesis CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $375,067
Hepatitis - C NIAID 5R01AI061684-05 Dendritic Cell mediated induction of Anti-HCV immunity BHARDWAJ, NINA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $571,176
Hepatitis - C NIAID 1K99AI077800-01 Studies of hepatitis C virus polarized cell entry and host factor requirements EVANS, MATTHEW ROCKEFELLER UNIVERSITY NY $90,000
Hepatitis - C NIDDK 5K24DK066144-05 Mentoring Junior Faculty: Hepatitis C Clinical Research FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $139,317
Hepatitis - C NIDA 5R01DA016017-06 Acute Hepatitis C Infection in Young Injectors PAGE-SHAFER, KIMBERLY UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $466,965
Hepatitis - C NIDA 5R01DA016159-05 Acute HCV Infection in Injection Drug Users EDLIN, BRIAN WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $650,470
Hepatitis - C NIAID 5R21AI072180-02 Towards Developing type 1a HCV cell culture model DASGUPTA, ASIM UNIVERSITY OF CALIFORNIA LOS ANGELES CA $188,843
Hepatitis - C NIDA 5K01DA023365-02 Dynamic Modeling of the HCV Epidemic in IDU HAHN, JUDITH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $165,521
Hepatitis - C NIDA 5R01DA016078-07 The Progression of Hepatitis C Among IDUs THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $712,636
Hepatitis - C NIAID 5R01AI071068-03 RNAi for the Treatment of Viral Hepatitis KAY, MARK STANFORD UNIVERSITY CA $377,376
Hepatitis - C NIAID 5R03AI069090-02 Role of mitochondrial core protein in Hepatitis C Virus pathogenesis OTT, MELANIE J. DAVID GLADSTONE INSTITUTES CA $95,648
Hepatitis - C NIAAA 5R01AA016231-03 Lifetime Drinking Patterns & HCV Treatment Outcomes RUSSELL, MARCIA PACIFIC INSTITUTE FOR RES AND EVALUATION MD $389,191
Hepatitis - C NIAID 5K01AI073193-02 Improving HIV and HCV outcomes in U.S. AIDS Drug Assistance Programs LINAS, BENJAMIN MASSACHUSETTS GENERAL HOSPITAL MA $135,815
Hepatitis - C NIDA 5R01DA019383-04 Staying Safe: Long-Term Injection Drug Users Who Have Avoided HIV & Hepatitis C FRIEDMAN, SAMUEL NATIONAL DEVELOPMENT & RES INSTITUTES NY $599,233
Hepatitis - C NIDA 5R01DA019841-09 Natural History of Hepatitis C Infection in HIV Disease COTTON, DEBORAH BOSTON UNIVERSITY MEDICAL CAMPUS MA $866,282
Hepatitis - C NIAID 5K01AI070001-02 Risk factors and prediction of liver disease in HIV/HCV LO RE, VINCENT UNIVERSITY OF PENNSYLVANIA PA $133,029
Hepatitis - C NIGMS 1R01GM081346-01A1 Structural basis of protein synthesis by the hepatitis C virus IRES RNA KIEFT, JEFFREY UNIVERSITY OF COLORADO DENVER CO $272,880
Hepatitis - C NIDA 5K23DA022143-03 Substance Abuse, HIV and HCV Treatments to Improve Health Outcomes in Drug Users BRUCE, ROBERT YALE UNIVERSITY CT $174,077
Hepatitis - C NIAID 5R43AI074255-02 Multiplexed mRNA quanitification using self-circularizing RNA probes KAZAKOV, SERGEI SOMAGENICS, INC. CA $299,965
Hepatitis - C NIDDK 5K08DK076598-02 The Pathogenesis of Steatosis in Hepatitis C Genotype 3 Infection JHAVERI, RAVI DUKE UNIVERSITY NC $124,308
Hepatitis - C NIDDK 5R21DK073649-02 MRI Quantification & Display of Hepatic Fat in Hepatitis C & NAFLD Patients HUSSAIN, HERO UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $186,200
Hepatitis - C NIAID 2R01AI060389-07 The Host Response to Hepatitis C Virus GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $383,372
Hepatitis - C NIAID 1R01AI075099-01A1 Role of HCV p7 and NS2 in infectious virus production RICE, CHARLES ROCKEFELLER UNIVERSITY NY $420,000
Hepatitis - C NIDDK 1R01DK074673-01A2 Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos KHALILI, MANDANA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $457,981
Hepatitis - C NIDDK 5R01DK074515-02 Role of HCV Sequence Variation in Pathology TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $318,528
Hepatitis - C NIAID 1R21AI065535-01A2 Developing an in vitro system for HCV propagation RAY, RATNA SAINT LOUIS UNIVERSITY MO $183,135
Hepatitis - C NIAID 5K23AI065630-04 Molecular Basis of Interferon Response in HCV JAIN, MAMTA UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $124,200
Hepatitis - C NIDA 1K23DA023467-01A1 Chronic Pain and Substance Use in Patients with Hepatitis C MORASCO, BENJAMIN OREGON HEALTH AND SCIENCE UNIVERSITY OR $165,533
Hepatitis - C NCI 1K22CA128866-01A1 HEPATOCELLULAR CARCINOMA AND HEPATITIS C: E2 MOLECULAR MECHANISMS BUCK, MARTINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $148,770
Hepatitis - C NIAID 5K23AI066943-04 Gender Effects of HIV and HCV on lipodystrophy, glucose disorders, and steatosis TIEN, PHYLLIS UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $121,770
Hepatitis - C NIAID 1K08AI075031-01A1 The Pathogenesis of Autoimmunity in Hepatitis C Virus Infection CHARLES, EDGAR ROCKEFELLER UNIVERSITY NY $140,400
Hepatitis - C NINDS 5K23NS051244-02 Relationship of Cytokines to Cognitive Functions in HCV HILSABECK, ROBIN UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $167,980
Hepatitis - C NIDA 5R01DA024565-02 Mechanisms of Hepatitis C Virus Evolution RAY, STUART JOHNS HOPKINS UNIVERSITY MD $503,137
Hepatitis - C NIAID 5R01AI070101-03 Mechanisms of hepatitis C virus persistence GRAKOUI, ARASH EMORY UNIVERSITY GA $401,835
Hepatitis - C NIDA 5R01DA019829-04 Epidemiology of HIV and Hepatitis C Among Injecting Drug Users in Tijuana STRATHDEE, STEFFANIE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $706,524
Hepatitis - C NIAID 5R01AI049168-08 HCV Replication and Immune Response in HIV Coinfection GRETCH, DAVID UNIVERSITY OF WASHINGTON WA $568,445
Hepatitis - C NIDDK 5K08DK076565-02 Bias in Retransplantation Survival Models: Selection Criteria and Hepatitis C BIGGINS, SCOTT UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $121,770
Hepatitis - C NIAID 5R43AI072802-02 Identification of an inhibitor of microRNA-122 in liver FREIER, SUSAN ISIS PHARMACEUTICALS, INC. CA $132,885
Hepatitis - C NIMH 5K23MH071181-05 HIV/HCV: Neuropsychiatric and Neurophysiologic Features RYAN, ELIZABETH MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $155,044
Hepatitis - C NIDDK 5R01DK073192-03 Liver Regeneration in the Transplant Setting OLTHOFF, KIM UNIVERSITY OF PENNSYLVANIA PA $154,566
Hepatitis - C NIDDK 5R01DK066917-05 Innate-like hepatic CD1d-reative NKT cells:Liver Disease EXLEY, MARK BETH ISRAEL DEACONESS MEDICAL CENTER MA $197,460
Hepatitis - C NIDA 5R01DA013806-09 HIV HCV Coinfection Antiviral Therapy and Fibrosis THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $499,538
Hepatitis - C NIDA 5K23DA018623-05 Pre-Chemotherapeutic Care of HCV Infected Drug Users FISHBEIN, DAWN MOUNT SINAI SCHOOL OF MEDICINE OF NYU NY $175,986
Hepatitis - C NIAID 1R43AI075829-01A1 Generation of novel HCV drugs through engineereing of the cssA gene ELHAMMER, AKE AUREOGEN BIOSCIENCES, INC. MI $300,000
Hepatitis - C NCCAM 5U01AT003571-03 Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease AFDHAL, NEZAM BETH ISRAEL DEACONESS MEDICAL CENTER MA $275,862
Hepatitis - C NIDDK 5U01AT003571-03 Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease AFDHAL, NEZAM BETH ISRAEL DEACONESS MEDICAL CENTER MA $82,500
Hepatitis - C NCCAM 5U01AT003560-03 A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $273,536
Hepatitis - C NIDDK 5U01AT003560-03 A phase I/II randomized, placebo controlled trial of silymarin for hepatitis C FRIED, MICHAEL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $71,088
Hepatitis - C NIAID 1R41AI072859-01A2 HCV Genotyping and Drug Resistance Testing by ESI/MS BLYN, LAWRENCE IBIS BIOSCIENCES, INC. CA $290,535
Hepatitis - C NCRR 5K23RR022206-03 HCV Kinetics and Determinants of Relapse SCOTT, JOHN UNIVERSITY OF WASHINGTON WA $153,792
Hepatitis - C NIAID 5R43AI072785-02 Development of a Proplylactic HCV Vaccine WHITACRE, DAVID VLP BIOTECH, INC. CA $300,000
Hepatitis - C NIDDK 5K24DK072036-04 Racial Disparities in Liver Diseases HOWELL, CHARLES UNIVERSITY OF MARYLAND BALTIMORE MD $194,250
Hepatitis - C NIAID 5R21AI070769-02 Hepatitis C virus infection and lipoproteins LUO, GUANGXIANG UNIVERSITY OF KENTUCKY KY $215,575
Hepatitis - C NIDDK 5R01DK065982-05 Immune Response to Hepatitis C in Liver Transplantation MOHANAKUMAR, THALACHALLOUR WASHINGTON UNIVERSITY MO $334,102
Hepatitis - C NCCAM 5U01AT003566-03 Phase I/II Trials of Silymarin for Chronic Liver Diseases Data Coordinating Cente BELLE, STEVEN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $393,253
Hepatitis - C NIDDK 5U01AT003566-03 Phase I/II Trials of Silymarin for Chronic Liver Diseases Data Coordinating Cente BELLE, STEVEN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $169,852
Hepatitis - C NIDDK 5R01DK066840-05 Novel markers for HCV-related HCC BERETTA, LAURA FRED HUTCHINSON CANCER RESEARCH CENTER WA $345,537
Hepatitis - C NIDDK 1F32DK082155-01 The role of interferon-stimulated genes in antiviral immunity SCHOGGINS, JOHN ROCKEFELLER UNIVERSITY NY $44,846
Hepatitis - C NIDDK 5K24DK078772-02 Patient-Oriented Research on Hepatitis in Special Populations CHUNG, RAYMOND MASSACHUSETTS GENERAL HOSPITAL MA $162,825
Hepatitis - C NIAID 5R01AI067926-03 CD8 T Cell Selective Pressure and HCV Sequence Evolution ALLEN, TODD MASSACHUSETTS GENERAL HOSPITAL MA $169,784
Hepatitis - C NIDDK 5R01DK068598-04 Racial Differences in IFN Transcriptional Response LAU, DARYL BETH ISRAEL DEACONESS MEDICAL CENTER MA $373,299
Hepatitis - C NCI 5R01CA123544-02 Biomarker for Hepatocellular Carcinoma WANDS, JACK RHODE ISLAND HOSPITAL (PROVIDENCE, RI) RI $237,762
Hepatitis - C NCI 5K07CA106458-04 Molecular Epidemiology of Chronic Liver Diseases HASSAN, MANAL UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $118,806
Hepatitis - C NIAID 5R21AI077018-02 The novel chromatin-based mechanism of antiviral resistance TARAKHOVSKY, ALEXANDER ROCKEFELLER UNIVERSITY NY $288,701
Hepatitis - C NIAID 5R01AI070827-03 High Throughput in vitro Hepatitis C Virus Screening UPRICHARD, SUSAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $231,928
Hepatitis - C NIAID 5R01AI068966-03 Cellular Immune Responses in Subjects Exposed to Hepatitis C KAMAL, SANAA AIN SHAMS UNIVERSITY EGYPT $233,034
Hepatitis - C NIAID 5U01AI070834-04 Development of Listeria-Based Clinical Consensus HCV Vaccine Candidates DUBENSKY, THOMAS ANZA THERAPEUTICS, INC. CA $354,663
Hepatitis - C NIAID 1F31AI071353-01A2 Type I Interferon Responses to Hepatitis C Virus EKSIOGLU, ERIKA UNIVERSITY OF FLORIDA FL $31,852
Hepatitis - C NIAID 5R03AI067440-03 Feasibility for non-Invasive screening for HCV related fibrosis MOHAMED, MOSTAFA NATL HEPATOLOGY/TROPICAL MED RES INST EGYPT $43,078
Hepatitis - C NIDDK 5U01DK061693-05 Studies of Pediatric Liver Transplantation LINDBLAD, ANNE EMMES CORPORATION MD $1,065,842
Hepatitis - C NIDA 5R01DA013324-10 Hepatitis C Pathogenesis & The Human Genome THOMAS, DAVID JOHNS HOPKINS UNIVERSITY MD $643,505
Hepatitis - C NIDA 5R01DA024563-02 INNATE IMMUNE DEFENSE AGAINST HCV and HIV: THE CHIMERIC MOUSE MODEL GALE, MICHAEL UNIVERSITY OF WASHINGTON WA $378,489
Hepatitis - C NIAAA 5R01AA012863-09 Mechanisms of Liver Injury by Hepatitis C and Alcohol WEINMAN, STEVEN UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $501,982
Hepatitis - C NIAID 5U01AI070802-03 Development of an Adenovirus based HCV Vaccine: preclinical safety and immunology NICOSIA, ALFREDO OKAIROS ITALY $180,033
Hepatitis - C NIDDK 5R01DK062847-06 Molecular Determinants of HCV Replication BEHRENS, SVEN-ERIK MARTIN LUTHER UNIVERS-HALLE-WITTENBERG GERM $87,788
Hepatitis - C NCCAM 5U01AT003573-03 A phase I/II trial of silymarin for chronic liver diseases REDDY, RAJENDER UNIVERSITY OF PENNSYLVANIA PA $255,596
Hepatitis - C NIDDK 5U01AT003573-03 A phase I/II trial of silymarin for chronic liver diseases REDDY, RAJENDER UNIVERSITY OF PENNSYLVANIA PA $76,416
Hepatitis - C NIAID 5R43AI072842-02 Liquid Crystal Diagnostic for Multiplex Hepatitis Screening WILLIAMS, JEFFREY PLATYPUS TECHNOLOGIES, LLC WI $299,978
Hepatitis - C NHLBI 5U01AI063589-05 Molecular profiling and immunomodulatory interventions SHAKED, ABRAHAM UNIVERSITY OF PENNSYLVANIA PA $472,639
Hepatitis - C NIAID 5U01AI063589-05 Molecular profiling and immunomodulatory interventions SHAKED, ABRAHAM UNIVERSITY OF PENNSYLVANIA PA $2,244,524
Hepatitis - C NIDDK 5K08DK070022-05 Insulin Resistance in Hepatitis C Virus Infection DELGADO, AYMIN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $128,946
Hepatitis - C NIDA 5K01DA018268-06 SELECTIVE INHIBITION OF HCV TRANSLATION BY TETRAPEPTIDE BIRK, ALEXANDER INSTITUTE FOR HEPATITIS & VIRUS RESEARCH PA $111,000
Hepatitis - C NIDA 5R21DA023399-02 Reducing HIV Risk Among Methamphetamine IDUs Through Peer Education RUMPTZ, MAUREEN MULTNOMAH COUNTY HEALTH DEPARTMENT OR $150,780
Hepatitis - C NIDA 1R01DA022914-01A2 Couples-Based HIV/STI Prevention for Injecting Drug Users in Kazakhstan EL-BASSEL, NABILA COLUMBIA UNIV NEW YORK MORNINGSIDE NY $676,058
Hepatitis - C NIAID 5F32AI069693-02 Novel role of NS2 in HCV infection DE LA FUENTE, CYNTHIA ROCKEFELLER UNIVERSITY NY $49,646
Hepatitis - C NCI 5R01CA125487-02 Surveillance for Hepatocellular Carcinoma among HCV-infected Veterans EL-SERAG, HASHEM BAYLOR COLLEGE OF MEDICINE TX $291,650
Hepatitis - C NIDDK 5U01DK062484-07 Living Donor Liver Transplantation Cohort Study BERG, CARL UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $170,038
Hepatitis - C NIDDK 5U01DK062483-07 Adult to Adult Living Donor Liver Transplantation Cohort Study EMOND, JEAN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $244,267
Hepatitis - C NIDDK 5U01DK062467-07 Adult Live Donor Liver Transplant-A Comparative Analysis ABECASSIS, MICHAEL NORTHWESTERN UNIVERSITY IL $465,991
Hepatitis - C NIDDK 5U01DK062494-07 Adult to Adult Living Donor Liver Transplantation Cohort Study SHAKED, ABRAHAM UNIVERSITY OF PENNSYLVANIA PA $119,233
Hepatitis - C NIDDK 5U01DK062536-07 Adult to adult living donor liver transplantation cohor* TROTTER, JAMES UNIVERSITY OF COLORADO DENVER CO $380,389
Hepatitis - C NIDDK 5U01DK062444-07 Adult to Adult Living Donor Liver Transplantation Cohort FREISE, CHRIS UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $252,773
Hepatitis - C NIDDK 5U01DK062496-07 ADLDT: An Opportunity to Expand the National Donor Pool BUSUTTIL, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES CA $121,265
Hepatitis - C NIDDK 5U01DK062505-07 Right Lobe Living Donor Liver Transplantation in Adults HAYASHI, PAUL UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $1
Hepatitis - C NIDDK 5U01DK062531-07 Adult to Adult Living Donor Liver Transplantation FISHER, ROBERT VIRGINIA COMMONWEALTH UNIVERSITY VA $208,685
Hepatitis - C NIDDK 5U01DK062498-07 Living donor liver transplant data coordinating center MERION, ROBERT UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $756,259
Hepatitis - C NIDDK 5R21DK079293-02 Transgenic mouse models of hepatitis C virus replication LUO, GUANGXIANG UNIVERSITY OF KENTUCKY KY $179,463
Hepatitis - C NIAID 1R01AI073219-01A2 NK/DC Cross-Talk and Antiviral Response MONTANER, LUIS WISTAR INSTITUTE PA $632,784
Hepatitis - C NCI 5R01CA122499-02 Oxidative Stress and Hepatocellular Carcinoma HUANG, TING-TING PALO ALTO INSTITUTE FOR RES & EDU, INC. CA $266,000
Hepatitis - C NIAAA 5R01AA015201-03 Psychoeducation for HCV and Alcohol Behaviors NORTH, CAROL UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $682,443
Hepatitis - C NCI 5K22CA129241-02 Hepatitis C Virus Replication and Intracellular Membrane Rearrangement KONAN, KOUACOU PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $154,978
Hepatitis - C NIDDK 5F32DK080650-02 Viral Dynamics of HCV Serine Protease Inhibitor Resistance RITOLA, KIMBERLY ROCKEFELLER UNIVERSITY NY $51,278
Hepatitis - C NIDA 5R01DA023405-02 HIV and HIV/HCV-Infection, Disease Progression, Oxidative Stress and Antioxidants BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $521,643
Hepatitis - C NIDA 5R01DA023570-02 Stabilize Addiction/Affect, Begin Inmates' Interferon for HCV of Liver (STAABIHL) FRIEDMANN, PETER RHODE ISLAND HOSPITAL (PROVIDENCE, RI) RI $244,622
Hepatitis - C NIDDK 5F32DK081193-02 Characterization of the HCV p7 Protein JONES, CHRISTOPHER ROCKEFELLER UNIVERSITY NY $52,898
Hepatitis - C NIAAA 5R01AA008169-19 HCV in Alcoholics WANDS, JACK RHODE ISLAND HOSPITAL (PROVIDENCE, RI) RI $323,323
Hepatitis - C NIDDK 5F32DK081259-02 Structural and Functional Studies of Hepatitic C Core and NS4B Proteins CALARESE, DANIEL ROCKEFELLER UNIVERSITY NY $49,646
Hepatitis - C NIAAA 5R43AA016712-02 Novel Engineered Synthetic Metallodrugs Directed Against HCV CHING, SAN METALLOPHARM, LLC OH $100,000
Hepatitis - C NIAID 1R01AI079031-01 Discovery of potent human antibodies for prevention of (recurrent) HCV infection LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $473,750
Hepatitis - C NIGMS 1R01GM085117-01 The Role of Arginine Methyltransferases in Interferon Signaling MOWEN, KERRI SCRIPPS RESEARCH INSTITUTE CA $379,000
Hepatitis - C NIGMS 2R01GM066978-05A2 Structure, dynamics, and function of the viroporins Vpu from HIV and p7 from HCV OPELLA, STANLEY UNIVERSITY OF CALIFORNIA SAN DIEGO CA $303,961
Hepatitis - C NIAID 1R21AI079352-01 Eliciting neutralizing antibodies against the HCV E2 envelope glycoprotein DRAGIC, TATJANA YESHIVA UNIVERSITY NY $249,000
Hepatitis - C NIAID 1K08AI079406-01 Novel antviral targets in Hepatitis C virus NS4B protein EINAV, SHIRIT STANFORD UNIVERSITY CA $130,599
Hepatitis - C NIDA 1R01DA024553-01A1 Treatment Study Using Depot Naltrexone(1/6)Philadelphia Coord/Data Mgmt Site O'BRIEN, CHARLES UNIVERSITY OF PENNSYLVANIA PA $591,774
Hepatitis - C NIDDK 1K01DK081736-01 Genetic Epidemiology of HCV-related Liver Disease WHITE, DONNA BAYLOR COLLEGE OF MEDICINE TX $157,946
Hepatitis - C NIDA 1R01DA024554-01A1 Treatment Studies Using Depot Naltrexone (4/6) Columbia Protocol Treatment Site NUNES, EDWARD NEW YORK STATE PSYCHIATRIC INSTITUTE NY $380,536
Hepatitis - C NIDA 1R01DA024549-01A1 Treatment Study Using Depot Naltrexone(2/6)Rhode Island Protocol Treatment Site FRIEDMANN, PETER RHODE ISLAND HOSPITAL (PROVIDENCE, RI) RI $355,583
Hepatitis - C NIDA 1R01DA024550-01A1 Treatment Study Using Depot Naltrexone(5/6)Baltimore Protocol Treatment Site KINLOCK, TIMOTHY FRIENDS RESEARCH INSTITUTE, INC. MD $309,076
Hepatitis - C NIDA 1R01DA024555-01A1 Treatment Study Using Depot Naltrexone(3/6)NY/Bellevue Protocol Treatment Site LEE, JOSHUA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $378,064
Hepatitis - C NIAID 1R01AI073963-01A1 Host Genetic Contribution to HCV Outcomes BLANTON, RONALD CASE WESTERN RESERVE UNIVERSITY OH $500,000
Hepatitis - C NCI 1R01CA127481-01A2 Hepatocarcinogenesis Secondary to Hepatitis C DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $293,416
Hepatitis - C NCI 1R21CA133266-01A1 Development of 3D Differentiated Hepatocyte Culture Systems for the Study of HCC UPRICHARD, SUSAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $200,550
Hepatitis - C NIAAA 1R21AA017252-01A1 Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Use/Abuse MUIR, ANDREW DUKE UNIVERSITY NC $224,250
Hepatitis - C NIDDK 2R01DK063222-05A2 Role of NK in Regulation of anti-viral T cell immunity HAHN, YOUNG UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $257,550
Hepatitis - C NCCAM 1R21AT003892-01A2 CAM Herbal Cocktails for Boosting Antioxident Activity to Treat Liver Disease HAWKE, ROY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $147,500
Hepatitis - C NIAAA 2R37AA014372-06A1 HCV, Alcohol and Host Defense SZABO, GYONGYI UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $368,063
Hepatitis - C NIDDK 1R41DK082087-01 Automated quantification of lipid droplets in fatty liver tissue sections MCDONOUGH, PATRICK VALA SCIENCES, INC. CA $151,754
Hepatitis - C NIAID 1R43AI078638-01A1 Calcium phosphate-interferon (CaP-IFN) particles for pulmonary delivery of IFN MORCOL, TULIN BIOSANTE PHARMACEUTICALS, INC IL $142,250
Hepatitis - C NIDDK 1F32DK083237-01A2 Molecular mechanism of cellular activation of the hepatitis C virus polymerase HECK, JULIE NEW YORK MEDICAL COLLEGE NY $49,646
Hepatitis - C NIAID 1F32AI080093-01 Reconstitution of Poliovirus and HCV RNA Replication Complexes on Membranes PTACEK, JENNIFER STANFORD UNIVERSITY CA $44,846
Hepatitis - C NIDDK 1F30DK082151-01 Regulation of hepcidin and iron metabolism in liver disease GOODNOUGH, JULIA UNIVERSITY OF CALIFORNIA LOS ANGELES CA $30,622
Hepatitis - C NIAID 1F32AI080122-01 Whole-genome siRNA screen for host genes supporting hepatitis C virus replication TAI, ANDREW MASSACHUSETTS GENERAL HOSPITAL MA $56,702
Hepatitis - C NINR 1P01NR010948-01 0002 Uncertainty management in patients awaiting liver transplant BAILEY, DONALD DUKE UNIVERSITY NC $78,819
Hepatitis - C NIDA 3R01DA019829-03S1 Epidemiology of HIV and Hepatitis C Among Injecting Drug Users in Tijuana STRATHDEE, STEFFANIE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $54,773
Hepatitis - C NIMH 1R01MH083553-01A1 Neurobehavioral Deficits in HIV/HCV Infection Pre/Post Anti-HCV Therapy HINKIN, CHARLES BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE CA $605,589
Hepatitis - C NIDA 2R01DA016065-06A1 HCV Disease Management in HIV- HCV Coinfected IDUs SULKOWSKI, MARK JOHNS HOPKINS UNIVERSITY MD $402,468
Hepatitis - C NIGMS 1R01GM087738-01A1 Inhibition of HCV as an Opportunistic HIV Co-infection HOSMANE, RAMACHANDRA UNIVERSITY OF MARYLAND BALT CO CAMPUS MD $342,938
Hepatitis - C NIAAA 1F31AA017853-01 Effect of alcohol and opioids on DC function in HCV and HIV infection YONKERS, NICOLE CASE WESTERN RESERVE UNIVERSITY OH $40,972
Hepatitis - C NIAID 5U19AI066313-04 0001 Immunologic Correlates of Liver Disease Progression KOZIEL, MARGARET BETH ISRAEL DEACONESS MEDICAL CENTER MA $154,065
Hepatitis - C NIAID 5U19AI066313-04 0002 Hepatitis C Virus- Induced Steatosis SIDDIQUI, ALEEM UNIVERSITY OF CALIFORNIA SAN DIEGO CA $160,781
Hepatitis - C NIAID 5U19AI066313-04 0003 Viral, T Cell, and Cytokine Determinants of Hepatic Stellate Cell Activation SCHUPPAN, DETLEF BETH ISRAEL DEACONESS MEDICAL CENTER MA $110,208
Hepatitis - C NIAID 5U19AI066313-04 9001 Clinical Core AFDHAL, NEZAM BETH ISRAEL DEACONESS MEDICAL CENTER MA $133,049
Hepatitis - C NIDA 1R01DA025932-01 Drug Interactions in Substance Abusers with HIV Infection FRIEDLAND, GERALD YALE UNIVERSITY CT $372,375
Hepatitis - C NIAID 1R01AI075090-01A2 Function of NS2 in Hepatitis C Virus Assembly and Release YI, MINKYUNG UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $302,000
Hepatitis - C NIAAA 1R01AA018001-01 Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection MCCANCE-KATZ, ELINORE UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $437,882
Hepatitis - C NIAAA 1R21AA018009-01 A Novel Humanized Mouse Model for Studying HIV/HCV Co-Infection and Liver Disease SU, LISHAN UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $173,738
Hepatitis - C NIDDK 1R43DK083104-01 Towards the creation of HCV-resistant liver cells for transplantation MILLAN, MARIA STEMCELLS, INC. CA $305,200
Hepatitis - C NIDDK 1F32DK083252-01 Interactions Between Hepatitis C and Serum Lipid Homeostasis COREY, KATHLEEN MASSACHUSETTS GENERAL HOSPITAL MA $54,842
Hepatitis - C NIDA 1R13DA026294-01 Sino-US Symposium in Drug Abuse, HIV and HCV Comorbidity HE, JOHNNY INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $25,000
Hepatitis - C NCI 5P01CA123328-02 0002 HEPATIC CARCINOGENESIS INDUCED BY HEPATITIS B VIRUS PreS2 MUTANT YEN, TIEN-SZE NORTHERN CALIFORNIA INSTITUTE RES & EDUC CA $469,011
Hepatitis - C NCI 5P01CA123328-02 0003 Role of Inflammation and DNA Damage-Repair in HCV Carcinogenesis LAI, MICHAEL UNIVERSITY OF SOUTHERN CALIFORNIA CA $272,798
Hepatitis - C NIDA 5P01DA012065-09 0006 NEUROCOGNITIVE HEATON, ROBERT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $355,741
Hepatitis - C NIDA 5P01DA012065-09 0007 NEUROMOTOR CALIGIURI, MICHAEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $14,761
Hepatitis - C NIDA 5P01DA012065-09 0010 BIOMARKERS LETENDRE, SCOTT UNIVERSITY OF CALIFORNIA SAN DIEGO CA $127,943
Hepatitis - C NIDA 5P01DA012065-09 0011 NEUROBIOLOGY MASLIAH, ELIEZER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $270,908
Hepatitis - C RMAP 1R03MH085690-01 Hepatitis C VIrus NS3 Helicase Inhibitor Discovery FRICK, DAVID NEW YORK MEDICAL COLLEGE NY $25,000
Hepatitis - C NCI 3R21CA125321-02S1 Variation in NTP use by the HCV polymerase and response to therapy TAVIS, JOHN SAINT LOUIS UNIVERSITY MO $20,868
Hepatitis - C NIAAA 3R01AA015201-02S1 Psychoeducation for HCV and Alcohol Behaviors NORTH, CAROL UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $32,805
Hepatitis - C NIDA 3R01DA022177-01A1S2 Opioids, HIV/HCV and Host Cell Innate Immunity HO, WENZHE CHILDREN'S HOSPITAL OF PHILADELPHIA PA $7,020
Hepatitis - C NIAAA 5U19AI040034-14 0007 HCV Infection Systems and Role of Neutralizing Antibodies in Hepatitis C RICE, CHARLES ROCKEFELLER UNIVERSITY NY $36,307
Hepatitis - C NIAID 5U19AI040034-14 0007 HCV Infection Systems and Role of Neutralizing Antibodies in Hepatitis C RICE, CHARLES ROCKEFELLER UNIVERSITY NY $263,201
Hepatitis - C NIAAA 5U19AI040034-14 0008 Global Transcriptional Responses in IFN Therapy for HCV GREENBERG, HARRY STANFORD UNIVERSITY CA $30,244
Hepatitis - C NIAID 5U19AI040034-14 0008 Global Transcriptional Responses in IFN Therapy for HCV GREENBERG, HARRY STANFORD UNIVERSITY CA $219,246
Hepatitis - C NIAAA 5U19AI040034-14 9001 Translational Core WRIGHT, TERESA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $26,423
Hepatitis - C NIAID 5U19AI040034-14 9001 Translational Core WRIGHT, TERESA UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $191,548
Hepatitis - C NIGMS 5P01GM073732-03 0001 STRUCTURE AND FUNCTION OF HUMAN TRANSLATION COMPLEXES DOUDNA, JENNIFER UNIVERSITY OF CALIFORNIA BERKELEY CA $519,180
Hepatitis - C NIGMS 5P01GM073732-03 0002 ROLE OF VIRAL IRES-RIBOSOME INTERACTIONS IN TRANSLATION CATE, JAMIE UNIVERSITY OF CALIFORNIA BERKELEY CA $232,441
12
 

Return To Top

    Download Readers: Download Adobe PDF Reader   Download Microsoft PowerPoint Viewer   Download Microsoft Word Viewer   Download Microsoft Excel Viewer
We would like to hear from you. Click here to provide your feedback Home  |   Frequently Requested Reports  |   Reports  |   Category Spending  |   CRISP  |   Glossary  |   FAQs  |   Links  |   Contact Us
Site Map  |   Accessibility Statement  |   Privacy Statement  |   Disclaimer  |   FOIA  |   Help Downloading Files
O E R logo - link to Office of Extramural Research N I H logo - link to the National Institutes of Health H H S logo - link to U. S. Department of Health and Human Services USA.gov logo - link to USA.gov Grants.gov logo - link to Grants.gov
Page Last Updated on January 24, 2008

This site is best viewed with Internet Explorer (6.0 or higher) or Mozilla Firefox (2.0).